Consolidated Transaction Processing v. Walgreens: Settled & Dismissed With Prejudice
Consolidated Transaction Processing LLC filed suit against Walgreens Co. in the Eastern District of Texas, asserting two patents covering targeted product offerings driven by personal data. The parties resolved all claims and counterclaims within 349 days, securing a dismissal with prejudice — extinguishing both sides’ litigation exposure on the asserted patents.
A targeted-advertising patent dispute resolved quietly in under a year
On December 6, 2023, Consolidated Transaction Processing LLC (CTP) filed a patent infringement action against Walgreen Co., d/b/a Walgreens, in the Eastern District of Texas before Judge Amos L. Mazzant. CTP asserted two patents — US8712846B2 and US8396743B2 — both directed at systems and methods for sending targeted product offerings based on personal information, a technology directly relevant to retail loyalty programs and personalized digital marketing platforms deployed by large pharmacy and consumer-goods retailers.
The case resolved without a trial or published claim construction ruling. On November 19, 2024 — 349 days after filing — the parties jointly announced they had reached a resolution of all claims and counterclaims. The Court dismissed both CTP’s infringement claims and Walgreens’ counterclaims with prejudice, with each party bearing its own legal costs. A notable carve-out in the dismissal order permits Walgreens to reassert its claims and counterclaims if any third party later asserts the same patents or the settlement agreement against Walgreens, unless CTP cures such assertion within 30 days.
The 349-day timeline from filing to dismissal is consistent with a case that reached commercial resolution before substantive merits litigation — no trial verdict, claim construction order, or summary judgment ruling appears in the public record. The with-prejudice dismissal on both sides suggests a structured settlement with licensing or covenant-not-to-sue terms, though the financial terms remain confidential. The third-party re-assertion carve-out is an unusual and commercially significant provision, suggesting Walgreens negotiated meaningful downstream protection beyond mere dismissal.
Filing to Dismissed with Prejudice in 349 days
349 days — resolved faster than the median E.D. Tex. patent case, suggesting early commercial pressure to settle
Dismissed with prejudice: what the settlement terms mean for both parties
Dismissal with prejudice ends the dispute permanently
A dismissal with prejudice under Fed. R. Civ. P. 41(a) is a final adjudication on the merits for preclusion purposes. CTP cannot refile these infringement claims against Walgreens on the same patents. Walgreens’ counterclaims — likely seeking invalidity or non-infringement declarations — are equally extinguished. The carve-out permitting Walgreens to revive its claims if a third party later asserts the patents adds an unusual layer of conditional protection rarely seen in standard dismissal orders.
Permanent bar on re-litigationCTP secures resolution but forfeits future Walgreens claims
For CTP, the with-prejudice dismissal suggests it secured whatever commercial value it sought — likely a licensing fee or structured payment — but permanently gave up the ability to sue Walgreens again on these patents. The 30-day cure window in the re-assertion carve-out signals CTP accepted an ongoing obligation to defend its licensing arrangements against third-party challenges targeting Walgreens, a material ongoing exposure for a patent licensing entity.
Settlement likely included licensingWalgreens exits with strong downstream protection
Walgreens obtained a with-prejudice dismissal of all claims, eliminating ongoing litigation costs and injunction risk. More significantly, the re-assertion carve-out in the order — allowing Walgreens to revive its invalidity and non-infringement counterclaims if a related third-party assertion surfaces — gives Walgreens a contractual defensive mechanism that survives the settlement. Fish & Richardson’s involvement for Walgreens is consistent with a negotiated outcome that secured durable IP protections.
Re-assertion carve-out retainedRetail personalization patents remain an active litigation risk
US8712846B2 and US8396743B2 cover targeted product offerings driven by personal information — technology embedded in virtually every major retailer’s loyalty and digital marketing stack. The swift settlement without a merits ruling leaves both patents’ validity undetermined, meaning other retailers operating similar personalization or targeted-offer systems face continuing exposure from CTP or successors-in-interest. The Eastern District of Texas remains a favored venue for such assertions.
Patents remain valid and enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Consolidated Transaction Processing, LLC | Company | Patent licensing entity — holder of US8712846B2 and US8396743B2 covering targeted personal-data-driven product offeringsSearch in Eureka ↗ |
| Defendant | Walgreen, Co. | Company | Walgreens Co. — major U.S. pharmacy and retail chain operating digital marketing and loyalty platformsSearch in Eureka ↗ |
| Plaintiff counsel | Robert Dean Kiddie , Jr. | Attorney | Counsel for Consolidated Transaction Processing, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Trevor James Beaty | Attorney | Counsel for Consolidated Transaction Processing, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Devlin Law Firm LLC (Wilmington) | Law Firm | Representing Consolidated Transaction Processing, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Shea Beaty | Law Firm | Representing Consolidated Transaction Processing, LLCSearch in Eureka ↗ |
| Defendant counsel | Adil A. Shaikh | Attorney | Counsel for Walgreen, Co.Search in Eureka ↗ |
| Defendant counsel | Neil J McNabnay | Attorney | Counsel for Walgreen, Co.Search in Eureka ↗ |
| Defendant counsel | Noel Franco Chakkalakal | Attorney | Counsel for Walgreen, Co.Search in Eureka ↗ |
| Defendant counsel | Ricardo Joel Bonilla | Attorney | Counsel for Walgreen, Co.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardson LLP | Law Firm | Representing Walgreen, Co.Search in Eureka ↗ |
| Presiding judge | Judge Amos L. Mazzant | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The dismissal order is notable for two features beyond standard with-prejudice language. First, it explicitly resolves Walgreens’ counterclaims — almost certainly invalidity and non-infringement declarations — with equal finality, preventing any revival by CTP. Second, the conditional re-assertion clause is a bespoke commercial negotiation preserved in a court order, giving Walgreens a rare self-help remedy if the patent rights it licensed become weaponised against it by a third party. No merits findings were made; the patents’ validity and claim scope remain entirely open for future litigation against other defendants.
US8712846B2 & US8396743B2 — Targeted product offerings via personal data
US8712846B2 (application US13/794781) and US8396743B2 (application US13/401827) are directed at transaction-processing and marketing systems that leverage personal information to deliver targeted product offerings to consumers. Both patents sit at the intersection of retail data analytics, customer transaction history, and automated offer generation — capabilities foundational to modern pharmacy loyalty programs, digital couponing, and personalized e-commerce recommendation engines. The application filing dates place both patents in the pre-GDPR era of data-driven marketing innovation.
From a competitive-risk perspective, these patents are broadly relevant to any retail or pharmacy operator, fintech platform, or e-commerce company that aggregates personal transaction data to generate individualized product recommendations or targeted promotions. CTP’s decision to assert both patents together against Walgreens — a company with one of the largest pharmacy loyalty databases in the U.S. — signals that the patent holder views the claims as covering integrated personalization pipelines, not merely isolated components. The absence of any invalidity ruling after this case strengthens the patents’ presumptive enforceability against future defendants.
Should your product team run an FTO against US8712846B2 and US8396743B2?
Any retailer, pharmacy chain, fintech provider, or digital marketing platform that uses customer transaction history or personal profile data to serve targeted product offers, coupons, or recommendations should treat these patents as active FTO priorities. The Walgreens settlement confirms CTP is willing to assert these patents against Tier-1 retailers, and the with-prejudice dismissal produced no invalidity findings that would benefit competitors. If your platform personalises offers at the point of sale, through a loyalty app, or via email/SMS marketing driven by purchase history, these claims warrant immediate review.
PatSnap Eureka’s FTO Search Agent can map the claim language of US8712846B2 and US8396743B2 against your product architecture in minutes, identify prior art that survived this litigation unraised, and flag continuation applications in the same family that may carry broader or more targeted claims. For in-house IP teams at retail and pharmacy companies, Eureka’s assignment tracking and litigation-history overlays provide a complete picture of CTP’s enforcement posture before your next product release.
Run a freedom-to-operate analysis on US8712846B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent cases: targeted-offer and transaction-processing assertions in E.D. Tex.
Cases involving personal-data-driven targeted marketing patents before Eastern District of Texas courts, including PAE assertions against retail and pharmacy defendants.
What this case signals for the retail personalization IP landscape
The CTP v. Walgreens settlement reflects broader PAE enforcement pressure on retailers running data-driven loyalty and targeted-offer programs.
E.D. Tex. remains a high-pressure venue for retail-tech patent assertions
CTP’s choice of the Eastern District of Texas — a historically plaintiff-friendly forum — before Judge Mazzant is consistent with a strategy designed to maximize settlement pressure. Retailers operating personalization or loyalty platforms should treat this venue’s activity as an early-warning signal and ensure proactive FTO analysis on data-driven marketing patents.
No merits ruling means US8712846B2 and US8396743B2 remain unchallenged
The dismissal with prejudice produced no claim construction, invalidity ruling, or prosecution history estoppel that could benefit the broader industry. Both patents survive fully enforceable. Companies in retail, pharmacy, fintech, or any sector using personal data to drive targeted offers should independently assess exposure to these patents before CTP files its next action.
Consolidated v Walgreen — key questions answered
CTP asserted US8712846B2 (application US13/794781) and US8396743B2 (application US13/401827) — both directed at systems and methods for sending targeted product offerings based on personal information. The case was filed December 6, 2023 in the Eastern District of Texas.
A dismissal with prejudice bars CTP from suing Walgreens again on these patents. However, it produces no invalidity or claim construction ruling. Both US8712846B2 and US8396743B2 remain fully enforceable against other defendants. The case resolved on commercial terms without any merits adjudication.
The dismissal order includes an unusual clause allowing Walgreens to revive its counterclaims — likely invalidity and non-infringement — if any person or entity asserts the CTP patents or the settlement agreement against Walgreens. CTP has 30 days from notice to cure such an assertion before Walgreens’ right to re-assert is triggered. This provision survives the settlement and provides Walgreens ongoing defensive protection.
CTP was represented by Devlin Law Firm LLC (Wilmington) and Shea Beaty, with attorneys Robert Dean Kiddie Jr. and Trevor James Beaty. Walgreens was represented by Fish & Richardson LLP, with attorneys Adil A. Shaikh, Neil J. McNabnay, Noel Franco Chakkalakal, and Ricardo Joel Bonilla.
The case was presided over by Judge Amos L. Mazzant in the Eastern District of Texas. It lasted 349 days, filed December 6, 2023 and closed November 19, 2024, resolving before any trial or substantive merits ruling was issued.
PatSnap Eureka searches patents and litigation data to answer instantly.